BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• FDA

  Raptor Pharmaceutical Inc. Receives FDA Approval Of Expanded Label For PROCYSBI To Treat Children Aged 2-6 Years With Nephropathic Cystinosis

  August 17, 2015

   · 

  4 min read
• Drug Development

  Cara Therapeutics, Inc. Initiates Phase II Trial Of Oral CR845 In Osteoarthritis

  August 17, 2015

   · 

  4 min read
• Drug Development

  SAGE Therapeutics Announces First Patient Treated In Phase III STATUS Trial Of SAGE-547 In Super-Refractory Status Epilepticus

  August 17, 2015

   · 

  7 min read
• Drug Development

  Summit Therapeutics Announces Phase Ib Modified Diet Clinical Trial Achieves Primary Objective In Duchenne Muscular Dystrophy

  August 17, 2015

   · 

  7 min read
• FDA

  GE Healthcare First to Win FDA Approval for Low Dose CT Lung Cancer Screening

  August 17, 2015

   · 

  6 min read
• Policy

  Omeros Corporation Announces Plan To File Infringement Suit Against ANDA Filer

  August 17, 2015

   · 

  6 min read
• Drug Development

  Relmada Therapeutics Receives Health Canada Clearance To Commence Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist

  August 17, 2015

   · 

  4 min read
• Drug Development

  DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding From NRC-IRAP To Support Expanded Research Program With Lead Product Candidate VAL-083

  August 17, 2015

   · 

  5 min read
• Business

  Eiger Biopharma Announces Key Operational Hires To Senior Management Team: Jim Welch, Chief Financial Officer; Jim Shaffer, Chief Business Officer

  August 17, 2015

   · 

  2 min read
• Deals

  CIT Serves As Joint Lead Arranger In $135 Million Senior Secured Credit Facility To Support Arlington Capital Partners’ Acquisition Of Avalign Tech

  August 17, 2015

   · 

  4 min read